Clinical Trial Update: Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Clinical trial update noting Phase 3 testing of pemetrexed with or without carboplatin for elderly patients with non-squamous non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Paraplatin (Carboplatin)

Snippet

Sponsor: Asan Medical Center | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN